Summary
In this study 23 cases of immune vasculities with predominance of neurological symptoms were analysed. Besides patient history and neurological examination, myelotomy is the most relevant means of diagnosis in immune vasculitis. For this reason myelotomy should be intergrated in routine diagnostic methods if the diagnosis immune vasculitis is discussed. Other laboratory parameters have no great relevance in the diagnosis of immune vasculitis. A higher specificity of antibody tests, especially in the case of ANA, might be able to replace myelotomy in the diagnosis of immune vasculitis. The relevance of laboratory parameters in the diagnosis of immune vasculitis in neurological patients was examined.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernhards J (1983) Immunogene Veränderungen des Knochenmarkmesenchyms bei Erkrankungen aus dem rheumatischen Formenkreis. Unveröffentliche Doktorarbeit (Med Hochschule Hannover)
Burkhardt R (1965) The bone marrow in systemic lupus erythematosus. Sem Hematol 2:29–46
Burkhardt R (1967) Histomorphologische Untersuchungen über die Rolle des Knochenmarkes bei rheumatischen Krankheiten. Z Ges Exp Med 143:1–66
Burkhardt R, Beil E (1971) Die diagnostische Aussage der Myelotomie. Klin Wochenschr 49:422–426
Calin A (1980) Die Behandlung der Kollagen-Krankheiten. Der Internist 21:697–701
Gemünd HR, Mitrenga D, Schumacher K (1978) Vergleichende Untersuchung zum Nachweis antinukleärer Antikörper unter besonderer Berücksichtigung des Lupus erythematodes disseminatus. Verh Dtsch Ges Inn Med 84:1307–1311
Gottwald W (1980) Neurologische und psychiatrische Syndrome des Erythematodes. Krankenhausarzt 53:127–129
Hamburger M, Hodes S, Barland P (1977) The incidence and clinical significance of antibodies to extractable nuclear antigens. Am J Med Sci 273:21–28
Helmke K, Schäfer B, Federlin K (1978) Vergleichende Untersuchung zum Nachweis antinukleärer Faktoren. Verh Dtsch Ges Inn Med 84:1304–1307
Herrmann D, Kunze K (1982) Elektromyographie und gezielte Muskelbiopsie bei Kollagenosen. In: Struppler A (Hrsg) Elektrophysiologische Diagnostik in der Neurologie. Thieme Verlag, pp 88–89
Hohmeister R, Bresnihan B, Hughes GRV (1978) Neuropsychiatrische Manifestationen bei Patienten mit Lupus erythematosus disseminatus. Schweiz Med Wochenschr 108:2007–2012
Johnson RT, Richardson EP (1968) The neurological manifestations of systemic Lupus erythematosus. Medicine 47:337–369
Korting GW (1967) Über einige Wesensunterschiede von Sklerodermie, Dermatomyositis und Lupus erythematodes acutus und die darauf basierende differente Therapie. Dtsch Med Wochenschr 92:281–288
Leibfarth JH, Persellin RH (1976) Characteristics of patients with serum antibodies to extractable nuclear antigens. Arthritis Rheum 19:851–856
Moore PM, Fauci AS (1981) Neurologic manifestations of systemic vasculitis. Am J Med 71:517–524
Northway JD, Tan EM (1972) Differentiation of antinuclear antibodies giving speckled staining patterns in immunofluorescence. Clin Immun Immunopathol 1:140–154
Rosenthal M (1976) Das Sharp-syndrom (“mixed connective tissue disease”). Schweiz Med Wochenschr 106:129–134
Rosenthal M, Stojan B, Müller W (1976) Differenzierung der antinukleären Antikörper zur Verbesserung ihrer diagnostischen Aussagekraft. Dtsch Med Wochenschr 101:379–384
Schumacher K (1982) Immunsuppressive Therapie der Autoimmunvaskulitiden und Bindegewebserkrankungen. Dtsch Ärzteblatt 79:37–45
Senff SH (1983) Die Bedeutung laborchemischer Untersuchungen für die Diagnostik neurologischer Krankheitsbilder bei Immunvaskulitiden. Unveröffentlichte Doktorarbeit (Hamburg)
Sharp GC, Irvin WS, La Roque RL, Velez C, Daly V, Kaiser AD, Holman HR (1971) Association of autoantibodies to different nuclear antigens with clinical patterns of rheumatic disease and responsiveness to therapy. J Clin Invest 50:350–359
Sharp GC, Irvin WS, Tan EM, Gould RG, Holman HR (1972) Mixed connective tissue disease — an apparently distinct rheumatic disease syndrome associated with a specific antibody to an extractable nuclear antigen (ENA). Am J Med 52:148–159
Sharp GC, Irvin WS, May CM, Holman HR, McDuffie FC, Hess EV, Schmid FR (1976) Association of antibodies to ribonucleoprotein and Sm-antigens with mixed connective-tissue dieseae, systemic Lupus erythematosus and other rheumatic diseases. J Med 295:1149–1154
Thomas L (1978) Labor und Diagnose. Die Medizinische Verlagsgesellschaft Marburg/Lahn
Wold RT, Young FE, Tan EM, Farr RS (1968) Deoxyribonucleic acid antibody: A method to detect its primary interaction with deoxyribonucleic acid. Science 161:806–807
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Hagenah, R., Senff, S.H. Importance of laboratory clinical investigation in the diagnosis of immune vasculitis with neurological manifestation. Eur Arch Psychiatr Neurol Sci 234, 92–96 (1984). https://doi.org/10.1007/BF00381213
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF00381213